Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE0000018X6
Hubei Jumpcan Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 8.02 bn CNY | 6.22 bn CNY |
| Gross profit | 6.35 bn CNY | 4.91 bn CNY |
| Operating income | 2.86 bn CNY | 1.88 bn CNY |
| EBIT | 2.43 bn CNY | 2.17 bn CNY |
| Net income | 2.53 bn CNY | 1.78 bn CNY |
| Diluted EPS – continuing operations | 2.76 CNY | 1.93 CNY |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hubei Jumpcan Pharmaceutical Co Ltd
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.
More stocks
- BW LPG Ltd (BWLPG.OL)
- Peyto Exploration&Development Corp (PEY.TO)
- Xinhua Winshare Publishing and Media Co Ltd (601811.SS)
- Sanil Electric Co., Ltd. (062040.KS)
- Intapp, Inc. (INTA)
- Sinomine Resource Exploration Co Ltd (002738.SZ)
- Post Holdings, Inc. (POST)
- Worley Parsons Ltd (WYGPY)
- Harvey Norman Holdings Ltd (HVN.AX)
- Glory View Technology Co. Ltd. A (301396.SZ)
- Thunder Software Technology Co Ltd (300496.SZ)
- New Hope Corporation Ltd (NHC.AX)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.